Table 1.
Up‐ or down‐regulated type‐special lipids in serum over twofold in adenocarcinoma (ADC), squamous cell carcinoma (SCC) or small cell lung cancer (SCLC)
| Lipid symbol | Fold | Lipid symbol | Fold |
|---|---|---|---|
| Up‐regulated type‐special lipids in SCC | |||
| PE 34:1 | 2.413927591 | ||
| Up‐regulated type‐special lipids in ADC | |||
| PS32:1 | 5.09765 | lysoPS15:1 | 11.06539345 |
| lysoPS20:2 | 17.472675 | lysoPS20:1 | 18.84013333 |
| PS30:1 | 19.00129722 | PS38:6 | 19.63504722 |
| lysoPS22:0 | 21.87011944 | PS36:3 | 26.31176111 |
| PS35:2 | 32.28302361 | PS35:1 | 33.0320804 |
| lysoPS16:0 | 35.35140556 | PS34:0 | 37.26924167 |
| PS34:3 | 50.05725958 | PS38:5 | 56.80440113 |
| PS38:2 | 59.53787133 | lysoPS22:4 | 61.52068609 |
| lysoPS20:3 | 63.70933056 | PS34:2 | 77.12018239 |
| lysoPS16:0 | 90.27303933 | lysoPS18:2 | 94.63135557 |
| PS36:0 | 100.2976925 | PS40:4 | 103.1282059 |
| PS38:4 | 110.1863088 | PS36:1 | 130.7878593 |
| PS40:5 | 141.3205679 | lysoPS22:6 | 144.0307609 |
| PS36:2 | 154.2687604 | PS38:3 | 170.3411736 |
| PS34:5 | 198.4490358 | PS40:6 | 237.5144428 |
| lysoPS18:1 | 271.9142996 | lysoPS20:4 | 422.4742472 |
| PS34:4 | 672.3756202 | lysoPS18:0 | 772.2299397 |
| Up‐regulated type‐special genes in SCLC | |||
| PC 40:1 | 2.452430888 | PC 40:4 | 3.035423914 |
| PE 38:1 | 6.919780093 | PE 42:7 | 8.224826755 |
| PE 40:3 | 12.80649768 | ||
| Down‐regulated type‐special lipids in ADC | |||
| PI 30:0 | 3.138308237 | PI 33:0 | 2.973606913 |
| PI 33:1e | 2.756489035 | PI 30:1 | 2.448825305 |
| PI 33:2e | 2.401033111 | PI 41:6 | 2.089884861 |
| Down‐regulated type‐special lipids in SCC | |||
| lysoPI 18:2 (sn‐1) | 3.174021852 | lysoPI 17:0 (sn‐1) | 2.686501872 |
| PG36:2 | 2.599471242 | PG35:2 | 2.599471242 |
| PG35:3 | 2.582298818 | PG35:1 | 2.573201161 |
| PG34:0 | 2.571442278 | PG39:7 | 2.57054263 |
| PG37:3 | 2.568963178 | PG35:4 | 2.560667263 |
| PG34:1 | 2.544927869 | PG36:0 | 2.540946865 |
| PG40:1 | 2.533367656 | PG37:6 | 2.519840973 |
| PG36:1 | 2.517071946 | PG33:1 | 2.509337261 |
| PG41:6 | 2.508824969 | lysoPG19:0 | 2.502973929 |
| PG35:5 | 2.498092401 | PG38:1 | 2.493572762 |
| PG37:4 | 2.478698123 | PG38:3 | 2.467495233 |
| PG37:2 | 2.466940759 | PG32:0 | 2.459511221 |
| PG37:5 | 2.457177588 | PG34:2 | 2.454550159 |
| lysoPG22:4 | 2.445162623 | lysoPG20:3 | 2.436735333 |
| lysoPG22:0 | 2.414907832 | PG40:4 | 2.412623442 |
| PG36:4 | 2.411241381 | lysoPG20:2 | 2.395150124 |
| PG33:2 | 2.394734033 | PG38:2 | 2.390172121 |
| PG40:5 | 2.37513548 | PG36:5 | 2.355426245 |
| PG38:4 | 2.350017951 | PG34:3 | 2.344849524 |
| lysoPG20:4 | 2.321610499 | PG31:0 | 2.318186638 |
| lysoPG20:5 | 2.302249424 | PG36:3 | 2.297141059 |
| lysoPG20:0 | 2.296203929 | lysoPG18:3 | 2.239909774 |
| lysoPG17:0 | 2.238864462 | PG40:8 | 2.236149498 |
| PG38:6 | 2.231677958 | PG38:5 | 2.21673939 |
| PG39:3 | 2.163513382 | PG40:6 | 2.162950362 |
| PG40:7 | 2.139169557 | ||
| Down‐regulated type‐special lipids in SCLC | |||
| lysoPC 20:5 | 3.679763534 | d171S1P | 2.622291711 |
| PE 35:5p | 2.377716405 | Cer120 | 2.227294449 |